1. Hong YP, Kim SJ, Lew WJ, Lee SH, Lee EK. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994. Int J Tuberc Lung Dis. 1998. 2:365–371.
2. Jin BW, Jang DJ. An analysis of tuberculosis patient management in private sector (in Korean). Tuberc Respir Dis. 1990. 37:399–406.
3. Hong YP, Kim SJ, Lee EG, Lew WJ, Bai JY. Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993. Int J Tuberc Lung Dis. 1999. 3:695–702.
4. Ministry of Health and Welfare. Korean National Tuberculosis Association. Report on the 7th tuberculosis prevalence survey in Korea. 1996. Seoul: Korean National Tuberculosis Association.
5. Korean National Institute of Health. Korean Institute of Tuberculosis. Annual report on the notified tuberculosis patients in Korea: based on Korean Tuberculosis Surveillance System. 2002. Seoul: Korean Institute of Tuberculosis.
6. Korean National Institute of Health. Korean Institute of Tuberculosis. Annual report on the notified tuberculosis patients in Korea: based on Korean Tuberculosis Surveillance System. 2003. Seoul: Korean Institute of Tuberculosis.
7. World Health Organization. Treatment of tuberculosis: guidelines for national tuberculosis, WHO/CDS/TB 2003.313. 2003. Geneva: WHO.
8. Fox W. General considerations in the choice and management of regimens of chemotherapy for pulmonary tuberculosis. Bull Int Union Tuberc. 1972. 47:49–67.
9. Horne NW, Ross JD. Modern drug treatment of tuberculosis. 1990. 7th ed. London: The Chest, Heart and Stroke Association;43–45.
10. Leff DR, Leff AR. Tuberculosis control policies in major metropolitan health departments in the United States: VI. standard practice in 1996. Am J Respir Crit Care Med. 1997. 156:1487–1494.
11. Ormerod LP, Bentley C. The management of pulmonary tuberculosis notified in England and Wales in 1993. J R Coll Physicians Lond. 1997. 31:662–665.
12. Simpson AJ, Watt B, Heald SH, Sudlow MF, Leitch AG. The management of pulmonary tuberculosis in adults notified in Scotland in 1993. Respir Med. 1998. 92:1289–1294.
13. Rothe TB, Karrer W. Short-course therapy of pulmonary tuberculosis: doctor's compliance. Tuber Lung Dis. 1996. 77:93–97.
14. Sumartojo EM, Geiter LJ, Miller B, Hale BE. Can physicians treat tuberculosis?: report on a national survey of physician practices. Am J Public Health. 1997. 87:2008–2011.
15. Ollé-Goig JE, Cullity JE, Vargas R. A survey of prescribing patterns for tuberculosis treatment amongst doctors in a Bolivian city. Int J Tuberc Lung Dis. 1999. 3:74–78.
16. Singla N, Sharma PP, Singla R, Jain RC. Survey of knowledge, attitudes and practices for tuberculosis among general practitioners in Delhi, India. Int J Tuberc Lung Dis. 1998. 2:384–389.
17. Bloch AB, Cauthen GM, Simone PM, Kelly GD, Dansbury KG, Castro KG. Completion of tuberculosis therapy for patients reported in the United States in 1993. Int J Tuberc Lung Dis. 1999. 3:273–280.
18. Hong YP, Kwon DW, Kim SJ, Chang SC, Kang MK, Lee EP, et al. Survey of knowledge, attitudes and practices for tuberculosis among general practitioners. Tuber Lung Dis. 1995. 76:431–435.
19. Vyas RM, Small PM, DeRiemer K. The private-public divide: impact of conflicting perceptions between the private and public health care sectors in India. Int J Tuberc Lung Dis. 2003. 7:543–549.
20. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet. 2001. 358:912–916.
21. Weil DE. Advancing tuberculosis control within reforming health systems. Int J Tuberc Lung Dis. 2000. 4:597–605.